Cancers (Basel). 2022 Jan 14;14(2):418.christineeulenburg1. Jan. 20231 Min. LesezeitRisk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study. Woelber et al. doi: 10.3390/cancers14020418
Risk for Pelvic Metastasis and Role of Pelvic Lymphadenectomy in Node-Positive Vulvar Cancer-Results from the AGO-VOP.2 QS Vulva Study. Woelber et al. doi: 10.3390/cancers14020418
JAMA. 2023 Oct Adherence to CPAP Treatment and the Risk of Recurrent Cardiovascular Events: A Meta-Analysis. Sánchez-de-la-Torre M, Gracia-Lavedan E,...
JAMA Oncol. 2023 Jul Efficacy of Endocrine Therapy Plus Trastuzumab and Pertuzumab vs De-escalated Chemotherapy in Patients with Hormone...
J Clin Oncol. 2023 AugDe-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+...
Comments